Neddylation pathway promotes myeloid-derived suppressor cell infiltration via NF-κB-mCXCL5 signaling in lung cancer

• Published in: International immunopharmacology 2022-12, Vol.113, p.109329-109329, Article 109329
• Main Authors: Zhou, Lisha, Lin, Xiongzhi, Zhang, Luyi, Chen, Siyuan, Chen, Jiahao, Zhou, Zhukun, Tang, Ajun, Ruan, Jiachao, Wang, Xiaojun, Chen, Baofu
• Format: Article
• Language: English
• Subjects: human CXCL6; Lung adenocarcinoma; MDSCs; murine CXCL5; Neddylation pathway; NF-κB signaling pathway
• ISSN: 1567-5769; 1878-1705
• DOI: 10.1016/j.intimp.2022.109329

•Inactivation of the neddylation pathway inhibits MDSC infiltration and impairs lung cancer growth.•High NEDD8 expression positively correlates with MDSC infiltration in lung adenocarcinoma.•Neddylation pathway regulates the expression of murine CXCL5 (human homolog CXCL6) via the NF-κB signaling pathway. Myeloid-derived suppressor cells (MDSCs), a population derived from immature myeloid progenitors, are present in the tumors of patients and highly protumorigenic. However, the molecular mechanisms regulating MDSC infiltration remain unclear. Neddylation pathway is overactivated in multiple cancers and has a significant role in tumor progression. We established a subcutaneous transplantation model of Lewis lung cancer in mice and showed that inactivation of neddylation pathway inhibits MDSC infiltration and impairs lung cancer growth. A high expression level of neuronal precursor cell-expressed developmentally downregulated protein 8 (NEDD8) is positively correlated with MDSC infiltration in human lung adenocarcinomas (LUADs). Moreover, inactivation of neddylation pathway inhibits the expression of murine CXCL5 (mCXCL5; human homolog CXCL6, hCXCL6), an important cytokine implicated in MDSC recruitment. Mechanistically, inactivation of neddylation pathway inhibits activity of Cullin-RING ligase 1, a typical neddylation substrate, and induces accumulation of phosphorylated IκBα and subsequent blockage of NF-κB translocation, thus suppressing transcriptional activation of mCxcl5 or hCXCL6. Collectively, our data suggest that neddylation-NF-κB-mCXCL5 axis is involved in MDSC recruitment to the tumor sites and demonstrate that neddylation pathway is a good therapeutic target for patients with LUAD, particularly those receiving anti-MDSC therapy.